K2 Principal Fund’s Envoy Medical COCH Stock Holding History

K2 Principal Fund’s Portfolio COCH Stock Details COCH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-158,930	Closed	-$1.6M	–	237
2023 Q1	$1.6M	Buy	+158,930	New	+$1.59M	0.22%	104

Other funds holding COCH

Atlas Merchant Capital New York $585K AUM 83.95% 1-Year Est. Return

Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return

Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.21B AUM 13.69% 1-Year Est. Return

Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return

Longfellow Investment Management Boston, Massachusetts $489M AUM 9.58% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

K2 Principal Fund's COCH Position: Q2 2023 in Review

K2 Principal Fund sold out of Envoy Medical (COCH) in Q2 2023, closing a stake of 158,930 shares — an estimated $1.6M sold.

K2 Principal Fund first reported a position in COCH in Q1 2023 and held it in 1 quarter. The position peaked at $1.6M in Q1 2023. 21 funds tracked by Wall St. Rank hold COCH as of Q2 2023.

K2 Principal Fund reported no remaining Envoy Medical position as of Q2 2023 after selling out during the quarter.
K2 Principal Fund sold 158,930 Envoy Medical shares in Q2 2023, an estimated $1.6M.
K2 Principal Fund first reported a position in Envoy Medical in Q1 2023 and held it in 1 quarter.
K2 Principal Fund's Envoy Medical position peaked at $1.6M in Q1 2023.
21 funds tracked by Wall St. Rank held Envoy Medical as of Q2 2023.

Based on K2 Principal Fund's 13F filing for Q2 2023, filed 15 Aug 2023.